Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-24T06:43:24.377Z Has data issue: false hasContentIssue false
  • English
  • Français

Genomic Research and Incidental Findings

Published online by Cambridge University Press:  01 January 2021

Brian Van Ness
Get access Rights & Permissions [Opens in a new window]

Extract

Medical practice is poised to incorporate genomescale testing into treatment decisions. However, broad genome testing in laboratories may lead to discoveries not anticipated, yet highly significant to the health of the patient. Understanding the complexity of our genome and its relationship to our health is an overwhelming task. Currently, much of the effort to unravel this complexity is in the realm of research. However, researchers are often neither qualified nor prepared to deal with incidental findings of genetic abnormalities that influence health and disease. These incidental observations, referred to recently by Issac Kohane et al. as the “incidentalome,” may lead to complex legal, ethical, and financial problems that may seriously complicate the role of the research community in medical genomics. Currently, most genetics researchers, while aware of the potential for incidental findings, simply do not want to deal with them.

Type
Symposium
Information
Journal of Law, Medicine & Ethics , Volume 36 , Issue 2 , Summer 2008 , pp. 292 - 297
Copyright
Copyright © American Society of Law, Medicine and Ethics 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Kohane, I. S. et al, “The Incidentalome: A Threat to Genomic Medicine,” JAMA 296, no. 2 (2006): 212–215; Lander, E. S. et al, “Initial Sequencing and Analysis of the Human Genome,” Nature 409, no. 6822 (2001): 860–921.CrossRefGoogle Scholar
Venter, J. C. et al, “The Sequence of the Human Genome,” Science 291, no. 5507 (2001): 1304–1351.CrossRefGoogle Scholar
International Human Genome Consortium, “Finishing the Euchromatic Sequence of the Human Genome,” Nature 431, no. 7011 (2004): 931–945.CrossRefGoogle Scholar
Sugiyama, E. et al, “Pharmacokinetics of Gemcitabine in Japanese Cancer Patients: The Impact of a Cytidine Deaminase Polymorphism,” Journal of Clinical Oncology 25, no. 1 (2007): 32–42.CrossRefGoogle Scholar
Wolf, S. M. et al, “Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations,” Journal of Law, Medicine & Ethics 36, no. 2 (2008): 219–248.CrossRefGoogle Scholar
Centers for Medicare and Medicaid Services, “Clinical Laboratory Improvement Amendments,” available at <http://www.cms.hhs.gov/CLIA/> (last visited December 30, 2007).+(last+visited+December+30,+2007).>Google Scholar
Turney, L., “The Incidental Discovery of Nonpaternity Through Genetic Carrier Screening: An Exploration of Lay Attitudes,” Qualitative Health Research 15, no. 5 (2005): 620–634.CrossRefGoogle Scholar
Unpublished observation of author (November 11, 2007).Google Scholar
Shalowitz, D. I. and Miller, F. G., “Disclosing Individual Results of Clinical Research: Implications of Respect for Participants,” JAMA 294, no. 6 (2005): 737–740.CrossRefGoogle Scholar
See Kohane, et al, supra note 1.Google Scholar
Knoppers, B. M. et al, “The Emergence of an Ethical Duty to Disclose Genetic Research Results: International Perspectives,” European Journal of Human Genetics 14, no. 10 (2006): 1170–1178.CrossRefGoogle Scholar
National Heart, Lung & Blood Institute (NHLBI), NHLBI Working Group on Reporting Genetic Results in Research Studies, Bethesda, MD, 2004, available at <http://www.nhlbi.nih.gov/meetings/workshops/gene-results.htm> (last visited November 11, 2007).+(last+visited+November+11,+2007).>Google Scholar
Id.Google Scholar
Council for International Organization of Medical Sciences (CIOMS), International Guidelines for Biomedical Research Involving Human Subjects, Geneva, 2002, available at <http://www.cioms.ch/frame_guidelines-nov_2002.htm> (last visited November 11, 2007).+(last+visited+November+11,+2007).>Google Scholar
World Health Organization (WHO), Genetic Databases: Assessing the Benefits and the Impact on Human and Patient Rights, Geneva, 2003, available at <http://www.law.ed.uk/ahrb/publication/online/whofinalreport.doc> (last visited November 11, 2007).+(last+visited+November+11,+2007).>Google Scholar
Id.Google Scholar
Consortium on Pharmacogenetics, Ethical and Regulatory Issues in Research and Clinical Practice, Minneapolis, 2002, available at <http://www.bioethics.umn.edu/News/pharm_report.pdf> (last visited November 11, 2007).+(last+visited+November+11,+2007).>Google Scholar
Id.Google Scholar
Id.Google Scholar
American Society of Human Genetics (ASHG), DNA Banking and DNA Analysis: Points to Consider, Bethesda, MD, 1998, available at <http://genetics.faseb.org/genetics/ashg/policy/pol-02.htm> (last visited November 11, 2007).+(last+visited+November+11,+2007).>Google Scholar
Canadian College of Medical Geneticists, “Policy Statement Concerning DNA Banking and Molecular Diagnosis,” Clinical Investigation of Medicine 14 (1991): 363–365.Google Scholar
See Kohane, et al, supra note 1.Google Scholar
Id.Google Scholar
Id.Google Scholar